Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | GSK3A | P49840 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5835820 | 0.98 | SIGMAR1 (0.51) | SIGMAR1POLBLTA4HGSK3AGSK3B | |
| SCHEMBL28875834 | 0.92 | SIGMAR1 (0.46) | SIGMAR1POLBLTA4HOPRM1 | |
| SCHEMBL28316372 | 0.92 | SIGMAR1 (0.46) | SIGMAR1POLBLTA4HGSK3AGSK3B | |
| SCHEMBL28316881 | 0.89 | POLB (0.45) | SIGMAR1POLBGSK3AGSK3BOPRM1 | |
| SCHEMBL925003 | 0.89 | SLC6A3 (0.46) | SIGMAR1GSK3AGSK3B | |
| SCHEMBL28230069 | 0.88 | KCNH2 (0.48) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL2761296 | 0.87 | SLC6A3 (0.44) | SIGMAR1 | |
| Trifluoromethanesulfonic Acid SCHEMBL28315387 | 0.85 | SIGMAR1 (0.40) | SIGMAR1LTA4HOPRM1 | |
| SCHEMBL28228839 | 0.81 | KCNH2 (0.48) | SIGMAR1 | |
| SCHEMBL667066 | 0.79 | MC4R (0.46) | SIGMAR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | claimed |
| CN-103665283-B | A kind of method preparing polyaryletherketone | BEIJING NORMAL UNIVERSITY (CN) | 2016-03-30 | — | — | CN | claimed |
| CN-103665283-A | Method of preparing polyaryletherketone | UNIV BEIJING NORMAL | 2014-03-26 | — | — | CN | claimed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | claimed |
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | disclosed |
| EP-4157912-B1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2024-05-22 | — | — | EP | disclosed |
| EP-3997183-B1 | METHOD FOR THE PRODUCTION OF ISOCYANURATES FROM URETDIONES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-11737345-B2 | Organic electronic material, ink composition containing same, and organic thin film, organic electronic element, organic electroluminescent element, lighting device, and display device formed therewith | RESONAC CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-20230192941-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | US | disclosed |
| EP-4157912-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | Covestro Deutschland AG (DE) | 2023-04-05 | — | — | EP | disclosed |
| US-20220348708-A1 | METHOD FOR PRODUCING ISOCYANURATES FROM URETDIONES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-11-03 | — | — | US | disclosed |
| EP-1651614-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-03 | — | — | EP | disclosed |
| EP-1648845-A1 | METHOD FOR EXTRACTING IMPURITIES USING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-26 | — | — | EP | disclosed |
| US-7005282-B2 | Enzymes coated with ionic liquid | POSCO AND POSTECH FOUNDATION (KR) | 2006-02-28 | — | — | US | disclosed |
| WO-2005111151-A1 | SECONDARY TREATMENT OF PIGMENTS IN IONIC LIQUIDS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
| WO-2005070896-A1 | MEHTOD FOR PRODUCING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005019183-A1 | METHOD FOR THE PRODUCTION OF PURIFIED 1,3-SUBSTITUTED IMIDAZOLIUM SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005019137-A1 | METHOD FOR EXTRACTING IMPURITIES USING IONIC LIQUIDS | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| US-20040087462-A1 | Enzymes cooated with ionic liquid | POSCO (KR) | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | SIGMAR1 400/4885POLB 2146/4885LTA4H 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.